Stockscreener 앱 받기
24.28
1.58%
-0.39
시간 외 거래:
24.28
전일 마감가:
$24.67
열려 있는:
$24.45
하루 거래량:
230.29K
Relative Volume:
0.78
시가총액:
$1.68B
수익:
$751.00K
순이익/손실:
$-74.57M
주가수익비율:
-22.01
EPS:
-1.1031
순현금흐름:
$-54.46M
1주 성능:
-6.62%
1개월 성능:
+16.56%
6개월 성능:
+86.91%
1년 성능:
+43.84%
1일 변동 폭
$23.60
$24.75
1주일 범위
$23.60
$25.93
52주 변동 폭
$12.56
$27.98
펄스 바이오 Stock (PLSE) Company Profile
명칭
Pulse Biosciences Inc
전화
510-906-4600
주소
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
24.28 | 1.71B | 751.00K | -74.57M | -54.46M | -1.1031 |
ISRG
Intuitive Surgical Inc
|
402.30 | 146.01B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.43 | 40.04B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
64.28 | 32.04B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
33.19 | 30.23B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
182.82 | 27.04B | 5.54B | 1.52B | 1.74B | 10.37 |
펄스 바이오 Stock (PLSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 개시 | Mizuho | Outperform |
| 2025-07-07 | 개시 | Oppenheimer | Outperform |
| 2021-07-27 | 개시 | Stephens | Overweight |
| 2021-03-11 | 개시 | Maxim Group | Buy |
| 2021-01-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-12 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | 개시 | H.C. Wainwright | Buy |
모두보기
펄스 바이오 주식(PLSE)의 최신 뉴스
Here's why Pulse Biosciences, Inc (PLSE) is a great momentum stock to buy - MSN
Discipline and Rules-Based Execution in PLSE Response - Stock Traders Daily
PLSE Technical Analysis & Stock Price Forecast - Intellectia AI
PLSE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
PLSE Q1 2026 Earnings: EPS Beat but No Revenue as Stock DeclinesEarnings Miss Alert - thelegaladvocate.com
Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - BioSpace
Pulse Biosciences (PLSE) Holds Steady: Key Levels in FocusButterfly Setup - thelegaladvocate.com
Here's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to Buy - Yahoo Finance
Pulse Biosciences Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Pulse Biosciences (PLSE) Extends Gains as Positive Momentum BuildsNHNL Ratio - thelegaladvocate.com
Assessing Pulse Biosciences (PLSE) Valuation After Recent Share Price Surge - Sahm
Pulse Biosciences Begins nPulse Study for Malignant Thyroid Tumor Treatment - Medical Product Outsourcing
Pulse Biosciences Earnings Call Highlights Clinical Momentum - TipRanks
Behavioral Patterns of PLSE and Institutional Flows - Stock Traders Daily
Pulse Biosciences, IncCommon Stock (NQ: PLSE - The Chronicle-Journal
PLSE accelerates cardiac catheter program after breakthrough AFib data - MSN
Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors. - The Globe and Mail
Pulse Biosciences CEO Buys 15,000 Shares: SEC Filing Details | May 2026News and Statistics - IndexBox
(SEC Amendment) Pulse Biosciences(PLSE.US) 10% Shareholder Buys US$13 Million in Common Stock - Moomoo
Pulse Biosciences director Robert W. Duggan acquires $13m in stock - Investing.com Nigeria
Pulse Biosciences director Robert W. Duggan acquires $13m in stock By Investing.com - Investing.com South Africa
Director Robert Duggan buys 660K Pulse Biosciences (PLSE) shares - Stock Titan
Pulse Bio rises after over $13M insider buying - MSN
Pulse Biosciences stock hits 52-week high at 26.33 USD By Investing.com - Investing.com Nigeria
Pulse Biosciences, Inc. Q1 2026 Financial Report – Revenue, Losses, and Key Corporate Updates - Minichart
Pulse Biosciences Announces Clinical Data From nPulse Vybrance System Study - Medical Product Outsourcing
Pulse Biosciences stock hits 52-week high at 26.33 USD - Investing.com India
Pulse Biosciences stock (US73242P1030): Q1 2026 net loss widens to $18.6M on early commercialization - AD HOC NEWS
PULSE BIOSCIENCES, INC. 1Q 2026: Revenue $401K, EPS ($0.27) — 10-Q Summary - TradingView
Pulse Biosciences (NASDAQ: PLSE) Q1 2026 results, cash burn and AF strategy - Stock Titan
Pulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026Slideshow - Seeking Alpha
[SCHEDULE 13D/A] PULSE BIOSCIENCES, INC. Amended Major Shareholder Report - Stock Titan
Pulse Biosciences Insider Bought Shares Worth $12,999,988, According to a Recent SEC Filing - Moomoo
Pulse Biosciences stock jumps after insiders buy $13.3M in shares - Investing.com Canada
Pulse Biosciences (PLSE) Co-Chairmen Invest $13.3M in Company St - GuruFocus
Pulse Biosciences (PLSE) Stock Soars After Insider Buying - GuruFocus
Pulse Biosciences (PLSE) Stock Surges 17% on Major $13M Insider Purchase - MEXC Exchange
Pulse Biosciences stock (US73242P1030): CEO buys $295K in shares - AD HOC NEWS
Pulse Biosciences (PLSE) Stock Jumps 17% After $13M Insider Buy - MEXC Exchange
펄스 바이오 (PLSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.52%
1.16%
자본화:
|
볼륨(24시간):